These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 425758)

  • 21. [Cutaneous allergic sensitivity in experimental allergic encephalomyelitis].
    Zhitnukhin IuL
    Biull Eksp Biol Med; 1973 Jun; 75(6):82-6. PubMed ID: 4778346
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of experimental allergic encephalomyelitis in guinea/pigs by liposome-associated human myelin basic protein.
    Strejan GH; Percy DH; St Louis J; Surlan D; Paty DW
    J Immunol; 1981 Nov; 127(5):2064-9. PubMed ID: 6170686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytotoxicity of sera against brain and spinal cord antigens in relation to lymphocytes of varying origin].
    Belokrylov GA; Zhitmukhin IuL; Sofronov BN
    Biull Eksp Biol Med; 1976 Aug; 82(8):968-70. PubMed ID: 1026300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental allergic encephalomyelitis as model of a neuro-allergic disease].
    Hitzschke B; Meyer-Rienecker H; Sayk J; Schröter P
    Z Arztl Fortbild (Jena); 1969 Dec; 63(24):1315-20. PubMed ID: 5403442
    [No Abstract]   [Full Text] [Related]  

  • 25. Interconnection of demyelination processes and inflammation in the dynamics of experimental allergic encephalomyelitis.
    Khizhnyak MG; Zhitnukhin YL; Konovalov GV; Semenov SP
    Acta Morphol Hung; 1988; 36(3-4):155-66. PubMed ID: 3151535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of the gliotoxie and demyelinating properties of serum in organ cultures of brain in experimental allergic encephalomyelitis].
    Ravkina LI; Goriunova AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(7):978-83. PubMed ID: 961299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis.
    Griffiths MR; Neal JW; Fontaine M; Das T; Gasque P
    J Immunol; 2009 Apr; 182(7):4368-77. PubMed ID: 19299737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of cyclophosphamide suppression of experimental allergic encephalomyelitis in Wistar rats.
    Paterson PY; Hanson MA
    J Immunol; 1969 Oct; 103(4):795-803. PubMed ID: 5349735
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cerebral gangliosides in dogs in experimental allergic encephalomyelitis].
    Kiroĭ RI; Mendzheritskiĭ AM; Vilkov GA
    Vopr Med Khim; 1982; 28(2):49-52. PubMed ID: 6281989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Scanning electron microscopy of the demyelinating process in recurrent experimental allergic encephalomyelitis].
    Iarosh OO
    Vrach Delo; 1991 Nov; (11):65-9. PubMed ID: 1801439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of circulating antibodies on the formation of inflammatory reaction in allergic encephalomyelitis].
    Wajgt A
    Neuropatol Pol; 1973; 11(5):235-44. PubMed ID: 4759159
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjuvanticity of mycobacterial RNA and poly A:U for induction of experimental allergic encephalomyelitis in guinea pigs.
    Gumbiner C; Paterson PY; Youmans GP; Youmans AS
    J Immunol; 1973 Jan; 110(1):309-12. PubMed ID: 4631072
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of non-encephalitogenic fraction isolated from human brain for the detection of EAE development in guinea-pigs.
    Pekárek J; Doutlík S; Vepreková A; Jedlicka P
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Aug; 140(2):177-83. PubMed ID: 4248066
    [No Abstract]   [Full Text] [Related]  

  • 35. [Role of neuroallergy in the pathogenesis of multiple sclerosis].
    Vilkov GA; Martirosian VV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):206-9. PubMed ID: 3885657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Disordered permeability of the hemato-encephalic barrier in the development of allergic processes of the nervous system].
    Zhitnukhin IuL; Sofronov BN
    Patol Fiziol Eksp Ter; 1989; (5):44-7. PubMed ID: 2482476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histochemical study of experimental allergic encephalitis. I. Data of neuropathology and lipid histochemistry.
    Dona G; Anghelescu N; Marcovici G; Petrescu A
    Rev Roum Neurol; 1971; 8(4):307-13. PubMed ID: 5140350
    [No Abstract]   [Full Text] [Related]  

  • 38. [Histoserologic studies of acute experimental allergic encephalomyelitis with special reference to complement binding complexes].
    Kochem HG; Kuwert E
    Verh Dtsch Ges Pathol; 1967; 51():418-21. PubMed ID: 4175850
    [No Abstract]   [Full Text] [Related]  

  • 39. Anti-T and anti-B cell sera in modulation of humoral and cellular reactivity induced by spinal antigen in chickens.
    Błaszczyk B; Giełdanowski J; Viljanen M; Katkiewicz M
    Arch Immunol Ther Exp (Warsz); 1987; 35(5):663-9. PubMed ID: 2458708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dyamics of the clinico-immunologic and histopathologic changes in the development of experimental allergic encephalomyelitis].
    Savenko SN; Tauber IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(2):171-5. PubMed ID: 4173467
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.